Jiaxing Tianhe withdraws BAL Flush SS 10 ml syringes from Europe after Ralstonia mannitolilytica infection outbreak
The manufacturer has suspended distribution of all BAL Flush SS 10 ml syringe batches produced up to 18 August 2026 across Europe. The decision will remain in force until the cause of the hospital infection outbreak is determined.

Ibrahim Boran · Unsplash License
- 0views
- 0likes and saves
- 0skips
In brief
- The manufacturer Jiaxing Tianhe has halted distribution in Europe of BAL Flush SS 10 ml syringes manufactured up to 18 August 2026.
- The reason is a hospital infection outbreak caused by the bacterium Ralstonia mannitolilytica, the source of which is not yet known.
- Facilities should check the batch numbers in their stock and stop using the products covered by the quarantine.
Scope of the quarantine
Jiaxing Tianhe Pharmaceutical Co., Ltd. has updated a safety notice concerning BAL Flush Syringe SS 10 ml, model BAL 464013 (Update to safety notice (TH-FSCA-20260001, TH-FSN-20260001) from Jiaxing Tianhe Pharmaceutical Co., Ltd. concerning prefilled BAL Flush Syringe SS 10 ml flushing syringes, model BAL 464013, issued due to a temporary quarantine across Europe of all batches manufactured up to and including 2026-08-18 pending final determination of the root cause of the hospital infection outbreak (Ralstonia mannitolilytica) – Office for Registration of Medicinal Products, Medical Devices and Biocidal Products). The suspension covers all batches manufactured up to and including 18 August 2026 and is temporary, applying across Europe as a whole.
Reason for the action
The reason is a hospital infection outbreak caused by the bacterium Ralstonia mannitolilytica. The root cause of the outbreak has not yet been determined, which is why the manufacturer has halted distribution of the entire batch rather than selected batches.
Documents and reference numbers
The matter is described in two documents: the original notice of 29 September 2026 and the update of 9 November 2026. Both carry the same reference number TH-FSCA-20260001 (notice TH-FSN-20260001).
What it means for patients and facilities
The syringes are used for flushing, so they reach hospitals and other facilities performing procedures on patients. Persons responsible for supplies should check the batch numbers of the stock they hold and stop using products covered by the quarantine until the matter is clarified. Questions about a specific procedure or a patient's health should be directed to the treating physician.
Read also
- Sterisets withdraws some batches of Steriflush water-filled ampoule syringes following plant inspection
Sources
Discussion0
- No comments from this perspective yet. Be the first.